Daniel Cho, country lead of Mundipharma Korea, heads the company with a strong commitment to integrity, trust and people-centered leadership, driven by a growth mindset and patient focus. Under his guidance, the company continues to be values-driven, united for patients while fostering a culture of respect, transparency and accountability. Mundipharma Korea, part of the U.K.-based health care platform, delivers optimal health care solutions for patients around the world through its specialty care expertise. Cho believes that sustainable business success begins with strong ethics, open communication and a deep commitment to patients. By fostering collaboration and embedding these principles in daily operations, he empowers employees to speak up and take ownership, and meaningfully contribute to both business and patient outcomes. Cho’s values-driven and patient-centered leadership has earned him the Most Respected CEO in Korea award for the second consecutive year in 2026. The recognition underscores his reputation across the business community for his commitment to employee development